In sporadic CRC cases, which arise from epigenomic silencing by hypermethylation of the MMR gene promotor, MMR deficiency may occur during tumor progression and display tumor heterogeneity (Fig. 1). The gene discussed is MRC1; the disease is hyperinsulinemic hypoglycemia, familial, 4.